Pharmacokinetics of Oral Calcium Carbonate in Parturients

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT06650930
Phase
EARLY_PHASE1
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Pharmacokinetics
  • Postpartum Hemorrhage
  • Pregnancy

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 45 Years
Healthy Volunteers
Not accepted

Interventions

  • Oral calcium carbonate — DRUG
    All participants receive a single, open-label dose of oral calcium carbonate 3000mg

Study Details

This study investigates the time course of change in calcium in the blood after a pregnant subject takes an oral dose of calcium carbonate (commonly marketed as "Tums"). This information is important for trials investigating whether calcium can reduce postpartum hemorrhage, bleeding after delivery.

Key Dates

Start date
Jan 31, 2025
Status verified
Nov 2024
Primary completion
Aug 31, 2025
Completion
Oct 31, 2025

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: Oral calcium carbonate
    Patients take a single dose of oral calcium carbonate 3000mg

Primary Outcome Measure

Ionized calcium concentration [ Time Frame: 4 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford Children's Health, Lucile Packard Children's HospitalStanfordCalifornia94305
Jessica Ansari, MD, MS
[email protected]
650-723-4000
Jordan Abrams, MD
[email protected]
650-723-4000

Find similar trials in Stanford, CA

By research site
Stanford Children's Health, Lucile Packard Children's Hospital· Stanford, CA

Related Studies